Recent studies have shown the efficacy of a combination therapy in a mouse model of pancreatic cancer, where thermally responsive elastin-like polypeptide (ELP) conjugated with iodine-131 radionuclides (131I-ELP) were delivered through nanoparticle albumin-bound paclitaxel. This evidence concerns the gene NR5A1 and pancreatic neoplasm.